Garuda Therapeutics

About:

Garuda Therapeutics develops off-the-shelf hematopoietic stem cell therapies to treat life-threatening diseases.

Website: https://garudatx.com/

Top Investors: Resilience, OrbiMed, Northpond Ventures, Cormorant Asset Management, Alexandria Venture Investments

Description:

Garuda Therapeutics develops off-the-shelf hematopoietic stem cell therapies to treat life-threatening diseases. It seeks to create a world that eliminates the dependency on donor or patient cells for blood stem cell transplants. Its platform technology for generating off-the-shelf, self-renewing blood stem cells is poised to provide patients with rapid and broad access to consistent, durable, HLA-compatible transgene-free blood stem cell therapies. The company was founded in 2021 and is headquartered Cambridge, Massachusetts.